Sb5 and Reference Adalimumab Show Cross-Immunogenicity in Patients with Inflammatory Bowel Disease or Rheumatoid Arthritis
AuthID
P-00Q-AJK
P-00Q-AJK
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service